Profile for European Patent Office Patent: 3960156
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for European Patent Office Patent: 3960156
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,039,800 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| 10,265,370 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| 10,406,199 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| 10,940,177 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| 11,179,434 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| 11,771,733 | Nov 6, 2035 | Azurity | QBRELIS | lisinopril |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
